Apposite's Primary Investments
Apposite seeks to invest in the best opportunities in emerging healthcare companies. The firm primarily focuses in Healthcare Services and Life Sciences companies. Apposite supports companies across all stages of company development, providing venture, development, growth and small mid market buyout capital.
Click on column headings to sort
| Company | Sector | Year of initial investment | Stage | Locations | Status |
|---|---|---|---|---|---|
| Ambit | Life sciences | 2007 | Series D venture | USA | Current |
| Ambrx | Life sciences | 2006 | Series C venture | USA | Current |
| Anaphore | Life sciences | 2009 | Series A venture | USA | Current |
| By The Bridge | Healthcare Services | 2006 | Staged buyout | UK | Current |
| CancerPartners UK | Healthcare Services | 2006 | Founding investment | UK | Current |
| Pharmakodex | Life sciences | 2006 | Series A venture | UK | Acquired |
| Serentis | Life sciences | 2006 | Series A venture | UK | Current |